Table of Contents

company-logo

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Allergy Therapeutics Dividend Announcement

• Allergy Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Allergy Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Allergy Therapeutics Dividend History

Allergy Therapeutics Dividend Yield

Allergy Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Allergy Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Allergy Therapeutics Financial Ratios

P/E ratio-5.87
PEG ratio-5.87
P/B ratio63.64
ROE-266.59%
Payout ratio0.00%
Current ratio1.63
Quick ratio1.01
Cash Ratio0.62

Allergy Therapeutics Dividend FAQ

Does Allergy Therapeutics stock pay dividends?
Allergy Therapeutics does not currently pay dividends to its shareholders.
Has Allergy Therapeutics ever paid a dividend?
No, Allergy Therapeutics has no a history of paying dividends to its shareholders. Allergy Therapeutics is not known for its dividend payments.
Why doesn't Allergy Therapeutics pay dividends?
There are several potential reasons why Allergy Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Allergy Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Allergy Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Allergy Therapeutics a dividend aristocrat?
Allergy Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Allergy Therapeutics a dividend king?
Allergy Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Allergy Therapeutics a dividend stock?
No, Allergy Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Allergy Therapeutics stocks?
To buy Allergy Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Allergy Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.